Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00074282
Status:
COMPLETED
Last Update Posted:
2023-06-29
First Post:
2003-12-10
Brief Title:
Pentostatin Cyclophosphamide and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04-14
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-06
Completion Date Type:
ACTUAL
First Submit Date:
2003-12-10
First Submit QC Date:
December 10 2003
Study First Post Date:
2003-12-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-14
Last Update Post Date:
2023-06-29
Last Update Post Date Type:
ACTUAL